HEALTHY PARTICIPANTS
Clinical trials for HEALTHY PARTICIPANTS explained in plain language.
Never miss a new study
Get alerted when new HEALTHY PARTICIPANTS trials appear
Sign up with your email to follow new studies for HEALTHY PARTICIPANTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early safety check for new drug UCB3101 in healthy volunteers
Knowledge-focused TerminatedThis study was an early, first-in-human trial to see if a single dose of UCB3101 is safe and tolerable in healthy adults aged 18 to 65. Researchers gave either the drug or a placebo and watched for side effects. The study was terminated early, so results are limited.
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE1 • Sponsor: UCB Biopharma SRL • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Experimental drug INCB000631 put to first safety test in humans
Knowledge-focused TerminatedThis early-stage study tested the safety and how the body handles the experimental drug INCB000631 in 24 healthy adults. Participants received either the drug or a placebo by mouth. The trial was terminated, so final results may not be available. It was not designed to treat any …
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Vitamin a booster for Kids' vaccines? small study cut short
Knowledge-focused TerminatedThis early-phase study looked at whether giving vitamin A along with the pneumococcus vaccine (Prevnar) helps children ages 1 to 4 build a stronger immune response. Only 22 healthy kids were enrolled before the study was stopped early. Researchers measured antibody levels in the …
Matched conditions: HEALTHY PARTICIPANTS
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:15 UTC